title: [Experimental study on the possibility of using live tularemia vaccine to increase resistance to heterologous infection disease].
abstract: In experiments on guinea pigs immunized with Francisella tularensis 15, or live tularemia vaccine (LTV), the level of heterologous protective effect to dangerous infectious diseases caused by Yersinia pestis, Burkholderia pseudomallei, B. mallei, Mycobacterium tuberculosis was studied. The study revealed that during the first 4 weeks after the subcutaneous immunization with LTV the level of resistance of the immunized animals to heterologous infective agent reliably increased as indicated by the survival rate of the animals, as well as by the survival time of those killed by infection, in comparison with the controls. Later (on day 150 after immunization) differences in death rate between the groups perceptibly decreased. Nevertheless, the 1 1/2-fold increase of the survival time of the challenged immunized animals in comparison with the controls proved the possibility of using immunization with LTV for the urgent prophylaxis and treatment not only of tularemia, but also of plague, glanders, melioidosis and tuberculosis.
authors.affiliation: Research Institute for Plague Control, Volgograd, Russia.
authors.forename: V I
authors.initials: VI
authors.lastname: Iliukhin
authors.forename: N G
authors.initials: NG
authors.lastname: Plekhanova
authors.forename: T V
authors.initials: TV
authors.lastname: Senina
authors.forename: O V
authors.initials: OV
authors.lastname: Stanovaia
authors.forename: N N
authors.initials: NN
authors.lastname: Kislichkin
mesh_terms: D000818:Animals; D001428:Bacterial Vaccines / Q000008:administration & dosage* / Q000276:immunology*; D004353:Drug Evaluation, Preclinical; D005604:Francisella tularensis / Q000276:immunology*; D005896:Glanders / Q000517:prevention & control*; D006168:Guinea Pigs; D007279:Injections, Subcutaneous; D008554:Melioidosis / Q000517:prevention & control*; D010930:Plague / Q000517:prevention & control*; D051381:Rats; D013997:Time Factors; D014376:Tuberculosis / Q000517:prevention & control*; D014611:Vaccination; D014613:Vaccines, Attenuated / Q000008:administration & dosage / Q000276:immunology
chemical_list: D001428:Bacterial Vaccines; D014613:Vaccines, Attenuated